Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Chest ; 161(3): 860-862, 2022 03.
Article in English | MEDLINE | ID: covidwho-2177381
3.
J Med Case Rep ; 16(1): 445, 2022 Nov 25.
Article in English | MEDLINE | ID: covidwho-2139400

ABSTRACT

BACKGROUND: Given the current climate of the pandemic, lung cancer patients are especially vulnerable to complications from severe acute respiratory syndrome coronavirus 2 infection. As a high-risk population group, these patients are strongly advised to receive coronavirus disease 2019 vaccination in accordance with Center for Disease Control and Prevention guidelines to minimize morbidity and mortality. In recent years, immunotherapy has taken a preeminent role in the treatment of non-small cell lung cancer with dramatic improvement in overall survival. Reactive lymphadenopathy following the administration of a coronavirus disease 2019 vaccination can confound the radiographic interpretation of positron emission tomography-computed tomography or computed tomography scans from lung cancer patients receiving immunotherapy. CASE PRESENTATION: Here, we present a case of a 61-year-old Caucasian female and former smoker who developed cervical, hilar, supraclavicular, mediastinal, and left retroauricular lymphadenopathy following her coronavirus disease 2019 booster vaccination. At the time, she had been receiving long-term immunotherapy for the treatment of advanced lung adenocarcinoma. Biopsy was pursued owing to concerns of treatment failure and confirmed recurrent malignancy. CONCLUSION: This case report highlights the importance of lymph node biopsies in lung cancer patients who present with contralateral lymphadenopathy following coronavirus disease 2019 vaccination to rule out tumor recurrence in this deserving patient population.


Subject(s)
COVID-19 Vaccines , COVID-19 , Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Lymphadenopathy , Female , Humans , Middle Aged , Carcinoma, Non-Small-Cell Lung/therapy , Carcinoma, Non-Small-Cell Lung/pathology , COVID-19/therapy , COVID-19 Vaccines/adverse effects , Immunotherapy , Lung Neoplasms/therapy , Lung Neoplasms/pathology , Lymphadenopathy/etiology , Neoplasm Recurrence, Local
4.
Chest ; 160(4): 1424-1432, 2021 10.
Article in English | MEDLINE | ID: covidwho-1275206

ABSTRACT

Escape Rooms are gaining prominence as education modalities; the use of principles of game design have been shown to augment knowledge acquisition in a fun, team-based learning experience ("edutainment"). In this report, we outline some of the medical literature and then provide our step-by-step approach and lessons learned when building what was, to our knowledge, the first continuing medical education Escape Room at a national scientific meeting. We then comment on how this innovative educational offering was reimagined the following year for remote (virtual) learning because of the COVID-19 pandemic.


Subject(s)
COVID-19/epidemiology , Education, Medical/methods , Motivation/physiology , Problem-Based Learning/methods , Congresses as Topic , Humans , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL